Skip to content

SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins

Non Genetic Factors in the Pathogenesis of Inflammatory Bowel Disease in Twins

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02383953
Enrollment
200
Registered
2015-03-10
Start date
2015-05-31
Completion date
2017-10-31
Last updated
2017-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis

Keywords

twins, IBD, UC, CD

Brief summary

This study aims to investigate the role of non-genetic factors in the pathogenesis of inflammatory bowel disease.An exploratory study to investigate differences between the epigenome, microbiota and functional immunology in twins discordant for inflammatory bowel disease.

Detailed description

Background: The inflammatory bowel diseases (IBD), Crohn's Disease (CD) and Ulcerative Colitis (UC), are debilitating conditions with a complex aetiology. The biggest risk factor for developing IBD is having an affected first degree relative. However when an identical twin is diagnosed with IBD, the other twin goes on to develop the condition in only 20-55% of cases. Recent research suggests the microbiota the ecosystem of bacteria within the gut may trigger disease in susceptible individuals. Another important research area is the epigenome changes to the structure and regulation of our genome which occur throughout our life. It is known that siblings of Crohn's Disease sufferers have a changes to the immune system characteristic of Crohn';s. However it is not known whether these changes are due to genetic similarity or shared environment. Comparison between mono and dizygotic twins elucidates the relative importance of genetic and environmental factors. Primary Objective: An exploratory study to investigate differences between the epigenome, microbiota and functional immunology in twins discordant for inflammatory bowel disease. Study Design: Multicentre basic science study involving human participants Planned sample size: 200 data subjects (100 twin pairs) Methodology: A) Identification of twin pairs where one or both have inflammatory bowel disease via: 1. IBD Nixon Twin and Multiplex Registry. 2. Advertising for twin pairs via BSG website and newsletters/patient support groups/social media sites/clinic posters. 3. Identification by study sites B) Obtaining formal written consent C) Collection of blood, stool and urine. D) The following analysis will be carried out: * Epigenetics (blood) DNA extraction and subsequent methylation analysis and bisulphate conversion with 450 Illumina beadchip assay * Functional immunology (blood) - flow cytometry of CD3, CD4 and CD8 cells. (London Twin pairs discordant for Crohn's Disease) * 16S rRNA gene sequencing (stool) - of bacterial DNA * Metabolomic profiling (Urine and stool) - using Nuclear Magnetic Resonance (NMR) and mass spectrometry E) Collection of dietary history information for the previous 72hr period Study Duration: 2 years (single visit).

Interventions

None listed

Sponsors

St Stephens Aids Trust
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Monozygotic twins discordant for IBD * Monozygotic twins concordant for IBD * Dizygotic twins discordant for IBD * Dizygotic twins concordant for IBD * Healthy controls

Exclusion criteria

* \<18 years old * Antibiotics within past 3 months of sample collection * Unable to give informed consent

Design outcomes

Primary

MeasureTime frame
Difference in DNA methylation patterns between twin pairs1 day (1 visit only)
Difference in microbiota composition and metabolomic profiles between IBD phenotypes1 day (1 visit only)
Comparison of microbiota composition and metabolic profiles with DNA methylation patterns1 day (1 visit only)
Difference in T cell phenotypes and antigen presenting cells between twin pairs discordant for IBD1 day (1 visit only)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026